Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs

American Journal of Veterinary Research

Volumn 66, Issue 3, 2005, Pages 425-431

  Bersenas, Alexa M E ^a   Mathews, Karol A ^a   Allen, Dana G ^a   Conlon, Peter D ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAMOTIDINE; OMEPRAZOLE; PANTOPRAZOLE; RANITIDINE;

ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; FEEDING; FEMALE; MALE; NONHUMAN; PH MEASUREMENT; STATISTICAL ANALYSIS; STOMACH ACID SECRETION; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANALYSIS OF VARIANCE; ANIMALS; BENZIMIDAZOLES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FAMOTIDINE; FOOD DEPRIVATION; GASTRIC ACIDITY DETERMINATION; GASTRIC JUICE; HISTAMINE H2 ANTAGONISTS; HYDROGEN-ION CONCENTRATION; OMEPRAZOLE; PROTON PUMPS; RANITIDINE; REFERENCE VALUES; SULFOXIDES;

ANIMALIA; CANIS FAMILIARIS;

EID: 17544371946     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.425     Document Type: Article

References (34)

1. Yamada I, Mizuta H, Goda T, et al. Gastric pH profile and its control in fasting Beagle dogs. Chem Pharm Bull 1989;37:2539-2541.
2. Akimoto M, Nagahata N, Furuya A, et al. Gastric pH profiles of Beagle dogs and their use as an alternative to human testing. Eur J Pharm Biopharm 2000;49:99-102.
3. Katz LB, Tobia AJ, Shriver DA. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs. J Pharmacol Exp Ther 1987;242:437-442.
4. Kromer W, Postius S, Riedel R, et al. BY 1023/SK&F INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions. J Pharmacol Exp Ther 1990;254:129-135.
5. Postius S, Brauer U, Kromer W. The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog. Life Sci 1991;49:1047-1052.
6. Larsson H, Mattson H, Sundell G, et al. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo. Scand J Gastroenterol Suppl 1985;108:23-34.
7. Larsson H, Carlsson E, Junggren U, et al. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 1983;85:900-907.
8. 2-receptor antagonists and proton pump inhibitors for the practicing physician. Best Pract Res Clin Gastroenterol 2001;15:355-370.
9. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990;99:345-351.
10. Bell NJV, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastroesophageal reflux disease. Digestion 1992;51(suppl 1):59-67.
11. Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med 2002;30(suppl 6):S351-S355.
12. Jones B, Kenward MG. Design and analysis of cross-over trials. London: Chapman & Hall, 1989;189-200.
13. 31-1). J Am Stat Assoc 1982;77:129-136.
14. Plumb DC. Veterinary drug handbook. 4th ed. Ames, Iowa: Iowa State University Press, 2002;351-352, 624-626, 757-759.
15. Matz ME. Gastrointestinal ulcer therapy. In: Bonagura JD, Kirk RW, eds. Kirk's current veterinary therapy XII. Philadelphia: WB Saunders Co, 1995;706-710.
16. Haskins S. Therapy for shock. In: Bonagura J, ed. Kirk's current veterinary therapy XIII. Philadelphia: WB Saunders Co, 2000;140-147.
17. PantoIV [product monograph]. Oakville, ON, Canada: Altana Pharma Inc, 2002.
18. Phillips JO, Metzler MH, Palmieri TL, et al. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 1996;24:1793-1800.
19. SAS/STAT user's guide: version 8 edition. Cary, NC: SAS Institute Inc, 1999.
20. Mela GS, Savarino V. Inaccuracy of hourly sampled pH measurements in describing the effects of antisecretory drugs on circadian gastric acidity. J Clin Pharmacol 1990;30:45-49.
21. Walt R. Twenty-four hour intragastric acidity analysis of the future. Gut 1986;27:1-9.
22. Armstrong D, Emde C, Blum AL. Twenty-four-hour intragastric pH-metry studies: easy to do but difficult to analyse. Eur J Gastroenterol Hepatol 1989;1:167-174.
23. Fimmel CJ, Etienne A, Cilluffo T, et al. Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists. Gastroenterology 1985;88:1842-1851.
24. Savarino V, Mela GS, Zentilin P, et al. Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. Scand J Gastroenterol 1989;24:434-439.
25. Chiverton SG, Burget DW, Hunt RH. Validation of pH dataloggers for pharmacologic studies. Scand J Gastroenterol 1989;24:975-981.
26. Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 1995;16:351-380.
27. Soll AH, Berglindh T. Physiology of isolated gastric glands and parietal cells: receptors and effectors regulating function. In: Johnson LR, ed. Physiology of the gastrointestinal tract. New York: Raven Press, 1987;883-906.
28. Papich MG. Antiulcer therapy. Vet Clin North Am Small Anim Pract 1993;23:497-512.
29. Mignon M, Chau NP, Nguyen-Phuoc BK, et al. Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships. Br J Clin Pharmacol 1982; 14:187-193.
30. Kromer W, Postius S, Riedel R. Animal pharmacology of reversible antagonism of the gastric acid pump, compared to standard antisecretory principles. Pharmacology 2000;60:179-187.
31. Friedman G. Famotidine. Am J Gastroenterol 1987;82:504-506.
32. 2-receptor antagonists? Aliment Pharmacol Ther 1987;1 (suppl 1):493S-503S.
33. Larson C, Cavuto NJ, Flockhart DA, et al. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube. Dig Dis Sci 1996;41:475-479.
34. Ekman L, Hansson E, Hanu N, et al. Toxicological studies on omeprazole. Scand J Gastroenterol Suppl 1985;108:53-69.